Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Prevention of protein loss” broadly refers to cellular mechanisms that stabilize, fold, or prevent the degradation or aggregation of proteins, ensuring that proteins maintain their correct structure and function over time. These mechanisms are collectively known as the proteostasis network and include processes such as regulated protein synthesis, molecular chaperone-mediated folding, the ubiquitin-proteasome system for targeted protein degradation, and autophagy-lysosome pathways for bulk degradation of proteins and organelles[3][4][1][2]. Maintenance of proteostasis is crucial for cellular health, stress resistance, aging, and prevention of various diseases including neurodegenerative diseases, cancer, and metabolic disorders. Disruption or failure of these systems can lead to pathological protein aggregation, loss-of-function states, and tissue dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prevention of protein loss.